BioSpace News Archive

Interventional Oncology Market, Analysis 2031 | Application in the Diagnosis and Treatment of Cancer and Cancer-related Problems

The increasing demand for minimally invasive procedures is driving the growth of the global market for interventional oncology.

July 18, 2022
·
7 min read
Immunoglobin Products Market to Witness Comprehensive Growth by 2031

Wilmington, Delaware, United States, Transparency Market Research Inc.: Immunoglobulin, likewise alluded to as antibody is a protein delivered by plasma cells and different lymphocytes.

July 18, 2022
·
6 min read
Heart Rate Monitor Watch Market to Surpass US$ 36.6 Billion by 2032 Amid Rising Incidence of Cardiovascular Disease

Fact.MR – A Market Research and Competitive Intelligence Provider: The global heart rate monitor watch market size is projected to be valued at US$ 36.6 Billion in 2032 and is likely to reach US$ 19.87 Billion in 2022.

July 18, 2022
·
8 min read
Business

Relief Therapeutics Appoints Serene Forte, Ph.D., MPH, as Senior Vice President, Head of Genetic Medicine

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, announced the appointment of Serene Forte, Ph.D., MPH, as Senior Vice President, Head of Genetic Medicine, effective July 18, 2022.

July 18, 2022
·
4 min read
Business

Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (Sodium Phenylbutyrate) New Drug Application (NDA) to the FDA for the Treatment of Urea Cycle Disorders (UCDs)

RELIEF THERAPEUTICS Holding SA, announced that its collaboration partner, ACER Therapeutics, Inc., for ACER-001 for oral suspension for the treatment of patients with urea cycle disorders, has resubmitted its New Drug Application for ACER-001 to the U.S. Food and Drug Administration.

July 18, 2022
·
4 min read
Policy

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

July 18, 2022
·
11 min read
Policy

COSELA®, the World’s First Comprehensive Myeloprotection Drug against Chemotherapy Damage, Wins Approval in China

On July 13 2022, Simcere Pharmaceuticals announced that the China National Medical Products Administration has conditionally approved COSELA®, an innovative myeloprotection drug jointly developed in China by Simcere and G1 Therapeutics.

July 18, 2022
·
8 min read
Business

Nomination of Dr. Kaushik Majumdar as GPI’s Interim Executive Director

The Global Phosphorus Institute (GPI) announced on June 16th 2022 the designation of Dr. Kaushik Majumdar as Interim Executive Director, with missions of operationalization of current Projects & Activities and further development of GPI.

July 18, 2022
·
2 min read
Business

DaVita Inc. Schedules 2nd Quarter 2022 Investor Conference Call

DaVita Inc., announced that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. Eastern Time.

July 18, 2022
·
1 min read
Business

Evelo Biosciences Announces Appointment of Marella Thorell as Chief Financial Officer

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, announced the appointment of Marella Thorell as Chief Financial Officer, effective September 1, 2022.

July 18, 2022
·
6 min read